A 75-year-old lady is diagnosed with thyroid malignancy and presents with low serum calcium. What is the most likely explanation?
Which of the following is a developmental odontogenic cyst?
Which of the following is NOT a marker for muscle tumors?
Metastatic calcification is characterized by which of the following?
Which statement is true regarding Interleukin-1 (IL-1)?
What is the normal range for Prostate-Specific Antigen (PSA)?
Virchow's triad includes all of the following, EXCEPT?
Splenosis means:
Acid mucin is best demonstrated by which stain?
All the statements related to neutrophil extracellular traps (NETs) are true except:
Explanation: **Explanation:** The correct answer is **Medullary Carcinoma of the Thyroid (MTC)**. This diagnosis is the most likely explanation for hypocalcemia in a patient with thyroid malignancy due to the cell of origin [1]. **1. Why Medullary Carcinoma is Correct:** MTC arises from the **Parafollicular C-cells** of the thyroid [4]. These neuroendocrine cells are responsible for the secretion of **Calcitonin** [1]. In MTC, there is a pathological overproduction of calcitonin. Calcitonin acts as a "hypocalcemic hormone" by inhibiting osteoclast activity in bones and increasing renal calcium excretion [4]. While many patients with MTC remain normocalcemic due to compensatory mechanisms [2], significant hypercalcitoninemia is a classic association with low serum calcium levels in thyroid oncology questions. **2. Why Other Options are Incorrect:** * **Papillary and Follicular Carcinoma:** These arise from the thyroid follicular cells [1]. They typically affect thyroid hormone levels (T3/T4) or remain euthyroid; they have no direct physiological link to calcium metabolism. * **Metastasis to Parathyroid:** While destruction of parathyroid glands could cause hypocalcemia (hypoparathyroidism), this is an extremely rare clinical scenario compared to the direct hormonal effect of MTC. **3. NEET-PG High-Yield Pearls:** * **Amyloid Stroma:** MTC is histologically characterized by nests of cells in a prominent amyloid stroma (derived from pro-calcitonin), staining positive with **Congo Red** (apple-green birefringence) [3]. * **Genetic Association:** Approximately 20-25% of cases are familial, associated with **MEN 2A and 2B** syndromes involving the **RET proto-oncogene** mutation [2]. * **Tumor Marker:** Calcitonin is used for both diagnosis and monitoring recurrence. CEA (Carcinoembryonic Antigen) is also often elevated [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1102-1103. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 664-665.
Explanation: **Explanation:** Odontogenic cysts are classified into two main categories based on their pathogenesis: **Developmental** (arising from remnants of the dental lamina or enamel organ) and **Inflammatory** (arising as a result of inflammation) [1]. **1. Why Dentigerous Cyst is Correct:** A **Dentigerous cyst** (also known as a follicular cyst) is the most common **developmental** odontogenic cyst. It originates from the separation of the follicle from around the crown of an **unerupted tooth**. It is attached to the cemento-enamel junction (CEJ) and is caused by fluid accumulation between the reduced enamel epithelium and the tooth crown. **2. Why the other options are incorrect:** * **Periapical Cyst (Radicular Cyst):** This is the most common **inflammatory** odontogenic cyst [1]. It arises from Malassez epithelial rests in the periodontal ligament following pulp necrosis due to dental caries or trauma [1]. * **Residual Cyst:** This is an **inflammatory** cyst. It is essentially a periapical cyst that remains in the jaw after the offending tooth has been extracted. * **Paradental Cyst:** This is an **inflammatory** cyst typically located on the buccal or distal aspect of a partially erupted mandibular third molar, usually associated with a history of pericoronitis. **High-Yield Clinical Pearls for NEET-PG:** * **Most common odontogenic cyst:** Radicular (Periapical) cyst. * **Most common developmental odontogenic cyst:** Dentigerous cyst. * **Radiological Hallmark:** Dentigerous cysts appear as a well-defined unilocular radiolucency associated with the crown of an impacted tooth (most commonly the mandibular 3rd molar). * **Potential Complications:** If left untreated, a dentigerous cyst can transform into an Ameloblastoma or Mucoepidermoid carcinoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 741-742.
Explanation: **Explanation:** The diagnosis of muscle tumors in histopathology relies heavily on **Immunohistochemistry (IHC)** markers, specifically those targeting the cytoskeleton. **Why Neurofilament is the correct answer:** **Neurofilaments (NF)** are intermediate filaments specific to **neurons**. They are used as markers for tumors of neural origin, such as neuroblastomas, ganglioneuromas, and pheochromocytomas. They are **not** expressed in muscle tissue; therefore, they cannot serve as a marker for myogenic tumors. **Analysis of other options:** * **Desmin (Option A):** This is the most specific and widely used marker for both skeletal and smooth muscle cells. It is an intermediate filament that integrates the sarcolemma with the Z-discs. It is positive in Rhabdomyosarcomas and Leiomyosarcomas. * **Actin (Option B):** Specifically **Muscle-Specific Actin (MSA)** and **Smooth Muscle Actin (SMA)** are primary markers for myogenic differentiation. SMA is particularly useful for identifying smooth muscle tumors and myofibroblastic proliferation. * **Intermediate Filament (Option D):** This is a broad category of cytoskeletal proteins. Both **Desmin** (muscle) and **Vimentin** (mesenchymal cells) are types of intermediate filaments found in muscle tumors. Since muscle tumors are mesenchymal in origin, they express these filaments. **High-Yield Clinical Pearls for NEET-PG:** * **Myogenin & MyoD1:** These are the most specific nuclear markers for **Rhabdomyosarcoma** (skeletal muscle) [1]. * **Vimentin:** A general marker for all mesenchymal tumors (sarcomas). * **Caldesmon:** A highly specific marker for **smooth muscle** differentiation, helping to distinguish leiomyosarcomas from myofibroblastic tumors. * **Cytokeratin:** The hallmark marker for epithelial tumors (carcinomas). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1224-1225.
Explanation: **Explanation:** Pathologic calcification is the abnormal tissue deposition of calcium salts. It is broadly categorized into two types: **Dystrophic** and **Metastatic** calcification. **1. Why Option A is Correct:** **Metastatic calcification** occurs in **normal tissues** whenever there is **hypercalcemia** (elevated serum calcium levels) [1], [3]. The excess calcium in the blood precipitates into tissues, primarily affecting interstitial tissues of the gastric mucosa, kidneys, lungs, and systemic arteries [2]. These sites are prone because they lose acid (due to excretion of H+ or CO2), creating an internal alkaline environment that favors calcium deposition [2]. **2. Why Other Options are Incorrect:** * **Option B (Hypocalcemia):** Low serum calcium levels do not lead to tissue calcification; instead, they typically manifest as neuromuscular irritability (tetany). * **Option C (Eucalcemia):** Normal serum calcium levels are characteristic of **Dystrophic calcification**. In dystrophic calcification, calcium deposits in **dead or dying (necrotic) tissues** despite normal systemic calcium metabolism. **3. NEET-PG High-Yield Pearls:** * **Common Causes of Metastatic Calcification:** Hyperparathyroidism (most common), Vitamin D intoxication, Bone resorption (multiple myeloma, bony metastasis), and Renal failure (secondary hyperparathyroidism) [1], [3]. * **Morphology:** On H&E stain, calcium appears as **basophilic (blue/purple)**, amorphous granular clumps [2]. * **Dystrophic vs. Metastatic:** Remember, Dystrophic = **D**amaged tissue/Normal Ca++; Metastatic = **M**etabolic derangement/High Ca++. * **Psammoma Bodies:** These are laminated, concentric calcifications seen in Dystrophic calcification (e.g., Papillary thyroid carcinoma, Meningioma, Serous cystadenocarcinoma of the ovary) [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 134-135. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 127-128.
Explanation: **Explanation:** Interleukin-1 (IL-1) is a pivotal pro-inflammatory cytokine that coordinates the acute inflammatory response. **Why Option D is Correct:** IL-1 (along with TNF) acts on the vascular endothelium to **upregulate the expression of adhesion molecules**, specifically E-selectin and ligands for integrins (VCAM-1 and ICAM-1) [2]. This process is essential for leukocyte rolling, adhesion, and subsequent transmigration (diapedesis) from the blood vessels into the site of injury. **Analysis of Incorrect Options:** * **Option A:** IL-1 is mainly derived from **activated macrophages**, not neutrophils [3]. Other sources include endothelial cells and some epithelial cells. * **Option B:** While IL-1 is pro-inflammatory, the ability to produce direct necrosis of tumor cells is a characteristic function of **Tumor Necrosis Factor (TNF)**, as its name implies. * **Option C:** The increase in expression of MHC (Major Histocompatibility Complex) proteins (Class I and II) is primarily a function of **Interferon-gamma (IFN-̳)**, which enhances antigen presentation. **High-Yield Clinical Pearls for NEET-PG:** * **The "Endogenous Pyrogens":** IL-1 and TNF act on the hypothalamus to increase prostaglandin (PGE2) synthesis, resulting in **fever**. * **Acute Phase Response:** IL-1 stimulates hepatocytes to produce acute-phase proteins (e.g., CRP, Fibrinogen). * **The Inflammasome:** IL-1̲ is produced as an inactive precursor (pro-IL-1̲) and must be cleaved by **Caspase-1** within the inflammasome complex to become active [1]. * **Therapeutic Link:** **Anakinra** is a recombinant IL-1 receptor antagonist used in the treatment of Rheumatoid Arthritis and Autoinflammatory syndromes. **References:** [1] "Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 196." [2] "Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 87." [3] "Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 97."
Explanation: **Explanation:** Prostate-Specific Antigen (PSA) is a glycoprotein enzyme secreted by the epithelial cells of the prostate gland. In clinical practice, it serves as a vital tumor marker for the screening and monitoring of prostate adenocarcinoma. **1. Why Option A is Correct:** The standard reference range for a "normal" PSA level is generally considered **< 4 ng/mL** [1]. At this level, the probability of prostate cancer is statistically low. However, it is important to note that PSA is organ-specific but not cancer-specific; it can be elevated in various non-malignant conditions [1]. **2. Analysis of Incorrect Options:** * **Option B (4-10 ng/mL):** This is known as the **"Gray Zone."** In this range, there is a significant overlap between Benign Prostatic Hyperplasia (BPH) and early-stage prostate cancer. Clinical decision-making here often requires calculating the "Free PSA ratio" (a low ratio <10% suggests malignancy) [1]. * **Option C (10-20 ng/mL):** Levels in this range carry a much higher suspicion for malignancy (approx. 50% chance), though severe prostatitis or recent instrumentation can also cause such elevations. * **Option D (> 20 ng/mL):** Levels above 20 ng/mL are highly suggestive of prostate cancer and often correlate with extracapsular extension or metastatic disease. **3. NEET-PG High-Yield Pearls:** * **PSA Velocity:** An increase of **> 0.75 ng/mL per year** is suspicious for malignancy, even if the total PSA is < 4 ng/mL [1]. * **PSA Density:** Calculated as Total PSA divided by Prostate Volume (via ultrasound). A value **> 0.15** is more indicative of cancer than BPH [1]. * **Age-Specific PSA:** Normal limits increase with age (e.g., < 2.5 for age 40-49; < 6.5 for age 70-79) due to increasing prostate volume [1]. * **False Elevations:** PSA can be transiently elevated by Digital Rectal Examination (DRE), prostatitis, ejaculation, or urinary tract infections. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 992-993.
Explanation: **Explanation:** **Virchow’s Triad** describes the three broad categories of factors that are thought to contribute to the formation of a thrombus (thrombogenesis) [1]. The correct answer is **D. Venous thrombosis**, because thrombosis is the *result* or the clinical outcome of the triad, not a component of the triad itself [3]. **Components of Virchow’s Triad:** 1. **Endothelial Injury (Option B):** This is the most important factor [3]. Damage to the vessel wall (arteries or veins) exposes subendothelial collagen, leading to platelet adhesion and activation of the coagulation cascade [2]. 2. **Stasis or Turbulent Blood Flow (Option A):** Normal blood flow is laminar. Stasis (common in veins) or turbulence (common in arteries) prevents the dilution of activated clotting factors and allows platelets to come into contact with the endothelium [3]. 3. **Hypercoagulability (Option C):** Also known as thrombophilia, this refers to an alteration in blood constituents (e.g., Factor V Leiden mutation, Protein C/S deficiency, or malignancy) that predisposes the blood to clot [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common component:** Endothelial injury is the primary driver of arterial thrombosis (e.g., atherosclerosis) [3]. * **Most common site for venous thrombosis:** Deep veins of the lower limbs (DVT). * **Lines of Zahn:** These are microscopic laminations found in thrombi formed in flowing blood, helping to distinguish a pre-mortem thrombus from a post-mortem clot. * **Trousseau Sign:** Migratory thrombophlebitis associated with visceral malignancies (pancreatic cancer), representing a state of hypercoagulability [4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 133-134. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 142-143. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 132-133. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 522-523.
Explanation: ### Explanation **Splenosis** is an acquired condition characterized by the autotransplantation of splenic tissue onto various surfaces, most commonly the peritoneum. **1. Why Option C is Correct:** The underlying mechanism involves the **traumatic or surgical rupture** of the splenic capsule. When the spleen ruptures, viable splenic pulp cells are released into the abdominal cavity. These fragments seed onto serosal surfaces (peritoneum, omentum, or even the pleura), develop their own blood supply, and grow into small, functional nodules of splenic tissue. Unlike the original spleen, these nodules lack a structured capsule and do not have a formal connection to the portal venous system. **2. Why the Other Options are Incorrect:** * **Option A (Infection):** Infection of the spleen is termed **splenitis** or a splenic abscess. * **Option B (Accessory Spleen):** This is a **congenital** condition (Splenunculus). Accessory spleens are found in ~10% of the population, usually near the splenic hilum, and possess a normal splenic structure and blood supply from the splenic artery [1]. * **Option C (Non-functioning spleen):** This is termed **asplenia** (congenital absence) or **autosplenectomy** (functional loss, commonly seen in Sickle Cell Anemia due to repeated infarctions) [2]. **3. High-Yield Facts for NEET-PG:** * **Clinical Significance:** Splenosis is usually asymptomatic and discovered incidentally. However, it can provide some residual immune function (pitting of RBCs), which may be beneficial after a splenectomy. * **Diagnosis:** On a peripheral smear, the absence of **Howell-Jolly bodies** [3] in a patient who has undergone splenectomy suggests the presence of splenosis or an accessory spleen. * **Imaging:** Heat-damaged Technetium-99m labeled RBC scan is the gold standard for identifying ectopic splenic tissue. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 567-568. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 631-632. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 570-571.
Explanation: **Explanation:** The correct answer is **Alcian Blue**. **1. Why Alcian Blue is correct:** Mucins are high-molecular-weight glycoproteins. They are broadly classified into **Acid mucins** (found in the intestinal tract and connective tissue) and **Neutral mucins** (found in the stomach and Brunner’s glands). Alcian blue is a basic dye that contains copper; it binds to the negatively charged carboxylated and sulfated groups of **acid mucins**, staining them a striking **blue**. By adjusting the pH (e.g., pH 2.5 vs. pH 1.0), pathologists can further differentiate between various types of acid mucins. **2. Why other options are incorrect:** * **Periodic Acid Schiff (PAS):** PAS primarily demonstrates **neutral mucins**, glycogen, and basement membranes. While some acid mucins may show weak positivity, PAS is the gold standard for neutral mucins and fungi. * **Van Gieson:** This is a connective tissue stain used to differentiate **collagen** (red) from muscle and cytoplasm (yellow). * **Reticulin:** This silver-based stain is used to visualize **Type III collagen (reticulin fibers)**, which form the structural framework of organs like the liver, bone marrow, and lymph nodes. **High-Yield Clinical Pearls for NEET-PG:** * **Combined PAS-Alcian Blue:** This stain is used to distinguish between neutral and acid mucins in the same section (e.g., detecting **Intestinal Metaplasia** in Barrett’s esophagus). * **Mucicarmine:** Another specific stain for acid mucins, often used to identify *Cryptococcus neoformans* (capsule) and adenocarcinoma. * **Colloidal Iron:** Also used for acid mucins; it is particularly useful in diagnosing **Chromophobe Renal Cell Carcinoma**. [1] **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 779.
Explanation: **Explanation:** **Neutrophil Extracellular Traps (NETs)** are a unique form of innate immune response where neutrophils extrude their nuclear chromatin to form a "web" that traps and kills pathogens. **Why Option B is the correct answer (The False Statement):** NETs actually provide a **high concentration** of antimicrobial substances at the site of infection. The DNA scaffold is impregnated with granular proteins (such as neutrophil elastase, cathepsin G, and myeloperoxidase). By concentrating these proteins in a localized fibrillary network, NETs prevent the diffusion of harmful enzymes, ensuring maximum lethal impact on microbes while minimizing collateral damage to distant healthy tissues. **Analysis of Other Options:** * **Option A:** NETs are often referred to as **"beneficial suicide"** (NETosis). During this process, the neutrophil membrane ruptures, and the cell dies to release its chromatin, sacrificing itself to contain the infection. * **Option C:** Morphologically, NETs are **extracellular fibrillary networks** composed of a DNA backbone and associated proteins, visible under fluorescence or electron microscopy. * **Option D:** NETs are a source of **self-antigens** (like citrullinated proteins and double-stranded DNA). If not cleared properly, they can trigger autoantibody production, contributing to **autoimmune diseases** like Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** NETosis is distinct from apoptosis and necrosis; it involves the enzyme **PAD4** (Peptidylarginine deiminase 4), which causes chromatin decondensation. * **Components:** The primary backbone is **DNA**, not protein. * **Clinical Link:** In SLE, patients often have a deficiency in **DNase I**, the enzyme responsible for degrading NETs, leading to prolonged exposure to nuclear antigens [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 92-93.
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free